ELIZABETH SALADIN: Open Payments
NPI 1326350752 · MOORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$742 in 40 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $177 · 2025 $742
Food & beverage: $742
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $164 |
| Lilly USA, LLC | 5 | $108 |
| AstraZeneca Pharmaceuticals LP | 5 | $95 |
| PFIZER INC. | 3 | $50 |
| SHIELD THERAPEUTICS INC | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| Optinose US, Inc. | 1 | $30 |
| Electromed, Inc. | 1 | $23 |
| Corcept Therapeutics | 1 | $20 |
| Medtronic, Inc. | 1 | $19 |
Products named: MOUNJARO, Ozempic, AIRSUPRA, Wegovy, ACCRUFER, ELIQUIS, SPRAVATO, Xhance.
Industry payments across OK — which companies pay providers there.
